Varian Announces Acquisition of humediQ Global GmbH

USA - English

• Deutschland - Deutsch

PALO ALTO, Calif., Aug. 6, 2018  /PRNewswire/ -- Varian (NYSE: VAR) today announced the acquisition of privately-held humediQ Global GmbH, the manufacturer of IDENTIFY, an automated patient identification, positioning and motion management system for radiation therapy. This acquisition expands Varian's motion-management portfolio and is part of the company's long-term growth and value creation strategy.  

IDENTIFY incorporates patient safety, quality, efficiency and surface-guided features in an automated workflow solution for surface-guided radiation therapy (SGRT). The IDENTIFY system features a palm reader for patient identification, a radio frequency identification (RFID) reader for proper accessory verification and placement on the treatment couch, automatic synchronization with the oncology information system, and SGRT cameras for proper patient positioning and motion monitoring throughout the treatment.

"Varian is focused on enabling sophisticated high-quality cancer care safely and effectively, around the globe," said Kolleen Kennedy, president of Varian's Oncology Systems business. "Varian and humediQ Global share a common mission in the worldwide fight against cancer and we are pleased to welcome the humediQ Global employees to the expanding Varian family in the region and add the comprehensive IDENTIFY solution to our portfolio."

"The IDENTIFY solution combines improved patient safety, an enhanced clinical workflow and surface guided imaging for high-quality radiation therapy treatments," said Christian Hieronimi, CEO of humediQ Global. "We are excited to join Varian and bring this solution to as many patients as possible worldwide. We share a passion for innovation, quality, and patient centered care and look forward to continue that mission together."

For more information visit https://www.varian.com/humediq

About Varian
Varian is a leader in developing and delivering cancer care solutions and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Press Contact
Mark Plungy
Director, Public Relations
+1 (650) 424-5630
[email protected]

Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
[email protected]

SOURCE Varian

Related Links

http://www.varian.com